Institute of Nursing Science, Department of Public Health, University of Basel, Basel, Switzerland.
University Department of Geriatric Medicine, FELIX PLATTER Hospital, Basel, Switzerland.
J Adv Nurs. 2022 Dec;78(12):4210-4220. doi: 10.1111/jan.15429. Epub 2022 Sep 2.
To develop a consensus-based instrument [MELIA] to assess the medication literacy of older home care patients to ultimately optimize medication safety.
This study was part of the project 'Study of Medication Safety in Home Care' (doMESTIC), which took place from 2016 to 2020 in Switzerland. The development process for the medication literacy assessment instrument encompassed six steps.
First, a scoping literature search was conducted in the Pubmed, CINAHL, EMBASE and Cochrane Library databases as 2) a basis for the development of assessment items. This was followed by 3) a cognitive interview with home care patients and 4) the first round of a Delphi process. Then, 5) a focus group interview with home care experts was conducted before 6) the second Delphi round. The project took place between August 2020 and June 2021. With these different steps, perspectives of both patients and various home care and medication safety experts were included in the development of the assessment instrument.
A detailed instrument consisting of 20 items as well as a 7-item short version were developed. The short version is intended for efficient preliminary screening to identify patients at high risk for medication management-related problems.
Medication literacy in patients 65 years and older receiving professional home care is a key issue in preventing medication errors. A targeted assessment, starting with an efficient short version of MELIA, allows for prioritization of patients for interventions to optimize medication safety while ensuring their independence as much as possible.
Systematic assessment of patients' medication literacy helps to provide them with targeted and individual support in their medication management to avoid medication errors and increase patient safety. The development of MELIA is a first step in providing an assessment instrument specifically for the home care setting.
Patient participation was an integral part of the instrument development. The initial 23 items were optimized based on cognitive interviews with four home care patients. The next steps of the instrument development were based on feedback of health care professionals-encompassing advance practice nurses, regular nurses, pharmacists and general practitioners-during a two-step Delphi process as well as a focus group discussion.
开发一种基于共识的工具[MELIA],以评估老年家庭护理患者的药物素养,最终优化药物安全性。
本研究是 2016 年至 2020 年在瑞士进行的“家庭护理药物安全研究”(doMESTIC)项目的一部分。药物素养评估工具的开发过程包括六个步骤。
首先,在 Pubmed、CINAHL、EMBASE 和 Cochrane Library 数据库中进行了范围广泛的文献检索,作为开发评估项目的基础。其次,对家庭护理患者进行了认知访谈,然后进行了第一轮 Delphi 流程。随后,在进行第二轮 Delphi 之前,与家庭护理专家进行了焦点小组访谈。该项目于 2020 年 8 月至 2021 年 6 月进行。通过这些不同的步骤,患者和各种家庭护理和药物安全专家的观点都被纳入了评估工具的开发中。
开发了一种详细的工具,包含 20 个项目和一个 7 个项目的简短版本。简短版本旨在进行高效的初步筛选,以识别出在药物管理相关问题方面存在高风险的患者。
接受专业家庭护理的 65 岁及以上患者的药物素养是预防药物错误的关键问题。有针对性的评估,从 MELIA 的高效简短版本开始,可以优先考虑患者进行干预,以优化药物安全性,同时尽可能确保他们的独立性。
系统评估患者的药物素养有助于为他们提供药物管理方面的针对性和个性化支持,以避免药物错误并提高患者安全性。MELIA 的开发是为家庭护理环境提供评估工具的第一步。
患者参与是工具开发的一个组成部分。最初的 23 个项目是根据对四名家庭护理患者的认知访谈进行优化的。工具开发的下一步是基于两步 Delphi 过程以及焦点小组讨论中医疗保健专业人员(包括高级执业护士、常规护士、药剂师和全科医生)的反馈。